(Q44359896)

2 December 2017

title

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience (English)

1 reference

2 December 2017

1 reference

9

1 reference

2 December 2017

Sorensen OH

1

1 reference

2 December 2017

Crawford GM

2

1 reference

2 December 2017

Mulder H

3

1 reference

2 December 2017

Hosking DJ

4

1 reference

2 December 2017

Gennari C

5

1 reference

2 December 2017

Mellstrom D

6

1 reference

2 December 2017

Pack S

7

1 reference

2 December 2017

Wenderoth D

8

1 reference

2 December 2017

Reginster JY

10

1 reference

2 December 2017

publication date

1 February 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

32

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

120-126

1 reference

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900946-8

7 January 2021

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900946-8

7 January 2021

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900946-8

7 January 2021

Risedronate reduces the risk of first vertebral fracture in osteoporotic women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900946-8

7 January 2021

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900946-8

7 January 2021

Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900946-8

7 January 2021

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900946-8

7 January 2021

10.1016/S8756-3282(02)00946-8

Identifiers

DOI

1 reference

2 December 2017

1 reference